You are here

You have a story to tell

We give it a voice.

You are here

About Us

Our Pharma & Life Sciences Solutions team is dedicated to helping medical and pharmaceutical brands and their agencies find the best content solution.

We can connect with Australia’s 99,000 medical practitioners with evidence-based content which informs and engages.

Leverage our local market expertise and global solutions platform to target HCPs worldwide to help you target:

  • 400+ healthcare journals

  • 80+ defined specialties

Tap into our expertise in producing:

  • Global and local conference summaries

  • Industry symposia highlights

  • Therapeutic updates

  • Conference news coverage

  • Specialty newspapers and digital publishing

  • Bespoke solutions

Pharma & Life Sciences Solutions. is a part of Elsevier…

#1 content provider of healthcare information solutions that enhance the performance of science, health and technology professionals.

Providing more than 25% of the world’s clinical content.

For 130 years, we have partnered with healthcare professionals to empower knowledge.

Helping 30 million scientists, clinicians, information professionals, students and educators with world- class information and innovative tools that help them make critical decisions, enhance their productivity, and improve their outcomes.

7000 staff in 24 countries. Part of RELX Group with customers in 180 countries and offices in 40 countries, employing 30,000 people.

We publish more than:

  • 2500 journals including the Lancet and Cell

  • 33,000 book titles

  • 150+ web based and digital solutions

We collaborate with:

  • 7000 journal editors

  • 70,000 editorial board members

  • 300,000 reviewers and 600,000 authors

Leverage our expertise for the best content solutions.

Elsevier Pharma & Life Sciences Solutions.
Local knowledge. Global support. Unique solutions.


What our customers say about our custom communications…

“WOW!!! The finished product looks amazing!! What a fantastic resource, chock-a block full of insightful commentary to support our strategy and patients. Fantastic!"

- Diagnostics lead

“We have used the infographic piece in the field and the feedback is overwhelmingly good. The reps are saying it is allowing them to start conversations which are leading nicely into discussions on treatments and products. It is proving to be an interesting piece.”

- Senior Marketing Manager

“I don’t have time to read everything that comes in but Cardiology News has the relevant clinical and research news from conferences and journals to keep me ahead.”

- Research surgeon

“A really well written piece that demonstrates how connected we are with these clinicians. Well done. Looking forward to future issues .“ 

- Oncology Associate Medical Director

“Excellent piece of work team!!! Well done. This will be wonderful in field and a useful educational piece.”

- Professional Relations Manager

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirectScopusElsevier Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries.